Animal Experiments

Kerry McCarthy Excerpts

Tuesday 5th February 2013 Westminster Hall

[Kerry McCarthy (Bristol East) (Lab)]

I congratulate the hon. Member for Crawley (Henry Smith) on securing this debate, and on outlining in such depth and detail the case against not animal experimentation per se, but the huge number of unnecessary experiments. He says that we need to get to a situation in which only absolutely essential tests continue. I would very much like one day to see a world in which there was no animal testing, but I accept that, at the moment, we should be lobbying and campaigning for a gradual incremental approach, highlighting the fact that there is so much duplication of unnecessary animal tests and that there are areas in which it is completely unethical to test products on animals.

Cosmetic testing is the one such area in which I think most people would support that kind of lobbying work. Indeed, public opinion polls show that the vast majority are against cosmetic testing on animals, which is one of those things that, if asked, people are very much against, but they struggle as consumers to put that into practice. People like me might spend ages looking at all the labels on everything—the Leaping Bunny logo is useful if people are trying to find a product that has not been tested on animals anywhere through the supply chain—but many others are misled by products such as Herbal Essences. People think that because something has “herbal” or “natural” in its name, all the ingredients must be derived from the plant world with no chemicals. They also extrapolate that those products are humane and not tested on animals, whereas we know that in most cases they are, or at least they are produced by companies that do a lot of animal testing.

It has taken 20 years to get to the stage where the cosmetic testing ban is about to come into force. In 1991, the British Union for the Abolition of Vivisection set up the European coalition of leading animal protection organisations with the aim of ending the use of animal testing for cosmetics. We now have the ban on the import and sale of animal-tested cosmetic products and ingredients, which comes into force on 11 March.

I am interested to know how that ban will be enforced—I believe that that is the responsibility of the Department for Business, Innovation and Skills. I recently asked a question of the Under-Secretary of State for Business, Innovation and Skills, the hon. Member for East Dunbartonshire (Jo Swinson) and was told that her Department is working with trading standards to develop guidance for local authority trading standards services on implementing the ban. My concern is that trading standards has many other things on its plate, that it is not well resourced and that it is affected by cuts, as are many other public sector bodies. Will the Minister tell us whether the guidance has already been published? Will there be consultation? What is the timetable for disseminating that guidance to local authority trading standards, and what training will there be on implementing the guidance? What enforcement action are local authority trading standards likely to take?

There needs to be more proactive testing of cosmetics during the import process, rather than waiting to try to catch people in shops and market stalls who are selling products that are still being tested. We ought to be able to stop those products from coming into the UK in the first place. The BUAV suggests that that could involve an inspector checking documentation to ensure that batches are compliant. Not only would that act as a deterrent to companies that might want to chance their arm, but it would uncover anything before it reached the market. When we consider the way in which the recent horsemeat situation came to light, everyone would agree that we should not find out after the event that something such as horsemeat has entered the food chain; we want to stop it coming into the country in the first place. Will the Minister examine the BUAV’s proposal to ensure that the ban is properly implemented?

The pledge to end testing household products on animals was set out in the coalition agreement in 2010. I remember in the run-up to the 2010 general election there was an event in Parliament at which speakers from the three main political parties pledged their support. Obviously, there is political will to do something, and the Government have said that no project licences will be granted for testing household products on animals.

When I recently tabled a parliamentary question asking for the definition of “household product,” the Minister for Policing and Criminal Justice answered:

“There is no authoritative definition of ‘household product’ in UK or European legislation.”

He said that new guidelines will apply to

“‘substances used in the household’”,

and that decisions will be made

“on a case by case basis.”—[Official Report, 22 January 2013; Vol. 557, c. 151W.]

Obviously, substances “used in the household” may cover a wide range of things, and I could imagine getting into a dispute about whether something will be covered by those rules.

As the hon. Member for Crawley said, there is no mention of any restriction on testing the ingredients of household products. As the Minister for Policing and Criminal Justice confirmed, Government figures for 2011 show that the number of tests on finished household products was zero. So implementing a ban on the testing of finished products will not achieve anything; it is the ingredients that are important. When the hon. Member for Hornsey and Wood Green (Lynne Featherstone), who was then a Minister in the Department, was asked about that in 2011, she said that when the ban is introduced, it will

“apply to both finished household products and their ingredients, although in practice mainly the latter are tested.”—[Official Report, 28 March 2011; Vol. 526, c. 80W.]

I would be grateful if the Minister elaborated on that. Does the ban apply to ingredients, as well as to finished products? If the ban applies only to finished products, how effective will it be? Or is the ban simply an empty gesture?

A new version of some household products seems to hit the market every few months. One moment we are told that a washing powder is the best ever and that it gets everything 100% white—it is marvellous, wonderful and cutting edge, and nothing could be better. Then, three months later, there is suddenly a new, improved version. That constant drive to get market share, to sell a new product and to present it as something different in some ways buys into the need to test more things that go into the product. Perhaps I am a bit old-fashioned, but we have plenty of household products that are capable of washing our clothes and cleaning our floors and windows. We do not need to introduce any new products or ingredients. We certainly do not need to do so at the expense of animals that have to have ingredients tested on them.

I hosted an event in Parliament on 16 January, which the hon. Member for Crawley attended. At that event, the Dr Hadwen Trust announced that it is funding the first professorial post in animal replacement science at Queen Mary, university of London. The post is an academic position, and another researcher will also be funded as part of the unit. They will be working solely on replacements for, and the reduction of, testing on animals. That means that the UK will be at the forefront of efforts to provide alternatives to animal testing. The new professor will be appointed in the next few months and will be based at the Blizard institute. The professor will particularly look at things such as developing in vitro models using human cells and tissue, and developing three-dimensional models in cutaneous gastroenterology and cancer research, which is a welcome move that provides credibility to the field of animal replacement.

People often think that the debate is just scientists against people who care about cuddly animals and have an emotional response, rather than people who are interested in the most effective scientific methods. At the launch, it was interesting that so many research scientists came up to me saying, “We don’t actually think that testing on animals is an effective way of doing it. We don’t think it gets the right results. Mice are genetically not the right animals to test something that we are developing to treat humans.” The professorial post creates credibility for the search for alternatives to testing on animals, which is important.

[Rehman Chishti (Gillingham and Rainham) (Con)]

I welcome what the hon. Lady is saying. She talked earlier about science and new technology. Does she welcome the fact that, last year, the National Centre for the Replacement, Refinement and Reduction of Animals in Research established 15 PhDs to consider alternatives to animal experiments? I think it is great to see both more scientists and more funding.

[Kerry McCarthy]

That is another welcome development. The National Centre for the Replacement, Refinement and Reduction of Animals in Research has done some good work, but more can be done. As we know, the number of animal experiments has gone up, partly because of medical developments, new forms of testing, and so on. I will judge the centre’s success by the reduction in the number of overall animal experiments, rather than success in one area and increased tests elsewhere.

[Angela Smith]

Is it not also important that the key Departments work together on reducing the incidence of animals used in research? The Home Office regulates research, the Department for Environment, Food and Rural Affairs funds much of the research and the Department for Business, Innovation and Skills often funds academia to undertake research on alternatives. Is it not important that those Departments should be committed to working together to deliver the coalition Government’s objective?

[Kerry McCarthy]

That is true, and I would add the Department of Health into the mix with its role in new drugs, safety standards, and so on. To an extent, the issue has suffered from being parked in the Home Office. The previous Minister, the hon. Member for Hornsey and Wood Green, for example, had the equalities brief and so much else to deal with that did not sit neatly with addressing the animal experimentation side of things. There is a tendency for the issue to be sidelined and not given the attention that it deserves. It would have been better to pull it together in a cross-cutting way under one post.

I have a couple of questions for the Minister. The recent legislation carrying forward the Animals (Scientific Procedures) Act 1986 came into force in January 2013. It requires that alternative non-animal research techniques be used in medical research if available. Researchers must ensure that, wherever possible, a scientifically satisfactory method or testing strategy not entailing the use of live animals should be used, and the number of animals used in projects should be reduced to a minimum. How will scientists know whether a non-animal alternative method is available, given that no central database currently exists? Without such a resource, how will the Home Office be able to monitor compliance properly or encourage the promotion of alternatives?

As I mentioned earlier, that topic leads into the ongoing problem of duplication. Currently, researchers have no way of knowing the results of previous experiments involving animals. An experiment at Cardiff university, for example, which involved sewing up the eyelids of newborn kittens had already been done elsewhere; it had turned out to be fruitless in finding a cure for lazy eye in children. Has the Home Office assessed the feasibility of introducing a central database that licence holders would have to search before submitting a project application? I understand that it has been discussed recently at European level in working groups, but that no progress was made. Why, and what steps will the Minister commit to take to help those discussions progress?

[Roger Williams (Brecon and Radnorshire) (LD)]

I thank the hon. Lady for giving way before coming to the end of her contribution. She is absolutely right about duplication, but one problem is that not all scientific work is published, because sometimes no journal is willing to publish it. Would it not be a good idea to have a system of open access, so that all work could be published on a database and everybody could have access to it, even if journals were not prepared to publish it?

[Kerry McCarthy]

The hon. Gentleman makes a good point. It is partly that results of some research are not publicly disseminated, but there is also an issue of commercial confidentiality where products for sale are involved. People do not want to reveal in what direction their thoughts are headed, in case someone steals their research and comes up with a similar product. They do not want to give their rivals a commercial advantage. I can see why drug companies, for example, would resist the idea of a central database, but we definitely need to go down the path of open access.

Finally, I hope that the Minister will welcome the creation of the professorial chair at Queen Mary, university of London. Can he do anything in conjunction with his colleagues at the Department for Business, Innovation and Skills to roll it out in the research departments of other universities in the UK?

[Mr Adrian Sanders (Torbay) (LD)]

It is a genuine pleasure to serve under your chairmanship for the first time, Mr Sheridan. I congratulate the hon. Member for Crawley (Henry Smith) on securing this important debate. The participants so far have certainly reflected quality rather than quantity.

Over the past few decades, many improvements have been made to the welfare of animals in research laboratories. We banned testing for cosmetic products and toiletries back in 1998, and conditions have improved under strict adherence to the three R’s. Unfortunately, as has been said, the number of animals used in scientific research continues to increase.

The guiding principles for the humane use of animals in scientific research are known as the three R’s: replace, reduce and refine. According to those principles, scientists must prove that there are no alternatives to using animals, use the minimum possible number of animals and refine their experiments to ensure that animals suffer as little as possible. The National Centre for the Replacement, Refinement and Reduction of Animals in Research is the organisation working on the coalition Government’s pledge to reduce the use of animals in scientific research. According to its research, drastic advances have been made in implementing the three R’s. As a result, thousands fewer animals are being used in certain experiments.

The problem of animal testing is global, and progress towards minimising its use has been hit and miss. As of March this year, EU law will prohibit not only animal testing for cosmetics within the EU, but importing any cosmetic products tested on animals outside the EU. Sadly, many companies responding to the growing appetite for cosmetic products among China’s middle classes are abandoning their cruelty-free status and resuming animal testing. Chinese law currently requires all cosmetics to be tested on animals to ensure that they are safe for humans. The law forces cosmetic companies to test every product in that way, even products that have been tested by other means and deemed safe.

There is knowledge within China of how to test cosmetics without animals. A grant from People for the Ethical Treatment of Animals helped train a number of Chinese scientists at Beijing technology and business university to test cosmetic ingredients without using animals. Perhaps we should add the Foreign and Commonwealth Office to the long list of Departments mentioned by the hon. Member for Bristol East (Kerry McCarthy) and involve it in cross-departmental action and discussion on the protection of animals from cruelty.

[Kerry McCarthy]

The hon. Gentleman might be aware that one of my other hats is shadow Foreign Office Minister. I talk to animal welfare groups, and then I meet ambassadors or visiting delegations. People have raised with me the dog meat trade in the Philippines, for example, but the problem is that, if our Foreign Office representatives go over there, that issue will be so far down their agenda that they never raise it. There are far more important issues of trade, defence, security and so on to raise. I accept entirely his point that the FCO should be involved as well.

[Mr Sanders]

I thank the hon. Lady for that intervention.

I hope that the training will ensure that if China changes the law requiring mandatory animal testing of cosmetics, scientists will know how to test products without using animals. The only way that the situation within China will change is if pressure is put on the Chinese Government to change their laws.

The claim that animal testing is needed for safety reasons does not hold up, given that the EU and many countries around the world manage to ensure that products are safe without involving animals. It is important that we all encourage cosmetic companies to put principles before profits and, rather than reversing years of progress, to stay firm by refusing to conduct tests on animals. Testing on animals is not necessary, and the companies that have started using animals again are doing so only to increase their profits.

We have a number of great companies here in Britain, such as The Body Shop, Lush and many others, which refuse to stock products tested on animals. I hope that we can do more to promote such companies and refuse to buy from the growing number of companies that are selling out by needlessly testing their products on animals. I hope that the Minister can give us some reassurance that the Government are aware of the growing problem and will introduce measures to reduce it.

--- Later in debate ---

[Mr Harper]

My hon. Friend makes a good point. There is sometimes a caricature of those involved in research. If they had alternatives to using animals, they would implement them; they use animals because there are not currently alternatives in all cases. My hon. Friend puts his finger on the issue: the use of animals for experiments, particularly in a country such as the UK, which has high standards, is expensive. Companies use animals only because there are not more effective remedies. Also, they are conscious that they could develop effective alternatives that would also be more cost-effective. However costly—in several senses—animal experiments are, if there are no alternatives, those cannot be used; but many pressures are pushing researchers towards the use of alternatives when they are available, and that is welcome to all of us, including my hon. Friend.

We also accept that regulation must not be overly bureaucratic, so we have made some small but important changes, allowing us to simplify the detail required in personal licences and the way we process applications for them. Another important change in the revised Act is the requirement placed on member states to collect and publish statistical information, on not just the number of animals used, but the severity of the procedures applied to them. Publication of information about the experience of the animals will be an advance in transparency. Combined with the mandatory requirement to publish non-technical summaries of authorised projects, that will help to inform the parliamentary and public debate .

[Kerry McCarthy]

To what extent is security an issue affecting the making public of the kinds of testing that are going on? I do not agree with some of the more extreme, violent protests used to highlight animal testing. Would that prevent some experiments from being made public?

[Mr Harper]

The hon. Lady raises an important issue. This may be a good time to pick up on the point made by my hon. Friend the Member for Crawley about section 24 of the 1986 Act, which, as he said, currently prohibits the disclosure by Home Office Ministers and officials, other than in their discharge of functions under the Act, of confidential information about the use of animals in scientific procedures. There are two reasons for the provision. One relates to the hon. Lady’s point, and covers information that might put individuals at risk from those people who sadly are not content with democratic decision making and debate, but choose to use violence—something that we in the House would all abhor. In addition, the provision protects intellectual property. I think that I can say a little more on that than my hon. Friend did.

The Government agree that section 24 is not framed satisfactorily. There is little room for manoeuvre, and it acts somewhat as a blanket ban on disclosing information. It can, for example, make it difficult for Home Office inspectors to share good practice between establishments. The hon. Lady raised that, and so did my hon. Friend the Member for Crawley. The problem is that clear consensus about what we should do did not emerge in the recent public consultation on the transposition of the European directive—whether we should repeal the section or change it in some way. There was a range of views, and we wanted, as my hon. Friend said, to give it further thought. As to a timetable—I think that is what he was after—I can be a bit more specific. We are doing that work now, over the next six months, and aim to report our conclusions to Parliament before the House rises for the summer. I hope that that gives some reassuring firmness to the timetable.

The problem was that many of the people who responded to the consultation did not like the status quo, but there was no really clear sense of what to replace it with. We must be mindful of the two issues I raised: intellectual property, which it is legitimate for researchers to protect; and the extent to which we need to protect those involved in important work. Changes to the regime for animal welfare should be made by Parliament, after legitimate public debate. They should not happen because people take it on themselves to try to drive out of business through intimidation and violence those who conduct lawful work. Those are the things that we shall be thinking through: being as open as possible, but with those two constraints. I hope that that is helpful, and that that approach is widely shared in the House.

It is probably worth picking up the point about statistics, which my hon. Friend the Member for Crawley and several other hon. Members raised. He is correct to say that the latest statistics, for 2011, showed that the number of animals used in experiments and testing was higher than it had been for some years. It was not the highest ever number. The high point was reached in statistics produced under the Cruelty to Animals Act 1876, which preceded the current legislation: in the 1970s about 5 million animals were used. Thus there has been a drop, but my hon. Friend is right to say that the number is going up.

An interesting point arises in that context, which brings me back to a point made by the hon. Member for Ashfield, about the United Kingdom’s reputation as a place to do life sciences and bioscience. I understand that that industry is growing in the UK, more quickly than the increase in the number of animals used; so the usage of animals for each £1 of research, or however one might characterise it, is falling, but more such work is being done in the UK. It seems to me that that is a good thing, because we want that work to be done here; we want those generally well-paid jobs to be in the United Kingdom. Also, because we have high standards of welfare in our animal testing regime, it is better for animals, if research is to take place anywhere in the world, for it to happen in the UK. However, if the size of the business in the UK grows, that may mean that even if the number of animals used for every given type of research falls, the overall number goes up.

Of course, the quickest way to reduce the number of animals would be to drive the work overseas, which would not be good for the United Kingdom, for jobs or for animal welfare. We must be thoughtful about the numbers. We should consider the size of the industry and the work that is being carried out, and whether we are driving down the proportion of animals being used in that work. We need to think about the global position. It is a coalition Government objective to get more of the life sciences business—the bioscience industry—in the United Kingdom. As the hon. Member for Ashfield said, the Opposition support that, and if we attract such business here more quickly than we manage to deliver on the three R’s, the number of animals that are used will rise. However, we may be driving down the rate at which they are used, while the industry grows. That is a bit of a conundrum, and I do not have the answer, but it shows that care should be exercised in using statistics.